Takeda Pharmaceutical Co Ltd

Issuers

Rating Agencies

Underwriters

View League Tables

To view dynamic league tables of the top Issuers, Rating Agencies and Underwriters, please log in or create a free Finsight.com account.

1 to 2 of 2

New Issue Deal Count

Recent New Issue

Takeda Pharmaceutical Co Ltd

CCY	SZE(M)	TNR	MTY	RNK	MO	SP	FI	TYPE	BNCH	IPT	GDNC	SPRD	CPN	NIC	PRICE
EUR	750.000	7	Jul-27	Sr. Unsecured	Baa2	BBB+	-	Fixed	Swaps	MS+130 a	MS+110 a	105	0.75%	-	99.63000
EUR	850.000	9	Jul-29	Sr. Unsecured	Baa2	BBB+	-	Fixed	Swaps	MS+150 a	MS+130 a	125	1%	-	99.40300
EUR	1,000.000	12	Jul-32	Sr. Unsecured	Baa2	BBB+	-	Fixed	Swaps	MS+180 a	MS+155 a	150	1.38%	-	99.46500
EUR	1,000.000	20	Jul-40	Sr. Unsecured	Baa2	BBB+	-	Fixed	Swaps	MS+225 a	MS+205 a	200	2%	-	98.65000

More Details

Tranche Comments

7 yr: Registration: Registered; Comments: EUR750m 7yr SEC-regd bmk. Part of 4-tr EUR. With USDs. Baa2/BBB+. BofA/MS(B&D). IPTs MS+130 area, guidance +110 area for exp 750m-1bn, tbp +105 for 750m. Books >1.35bn (peak 1.6bn), HR 96% vs DBR 02/27s +14.8 @ 106.22. MWC B+25, 2mPC>.; 9 yr: Registration: Registered; Comments: EUR850m 9yr SEC-regd bmk. Part of 4-tr EUR. With USDs. Baa2/BBB+. BofA/MS(B&D). IPTs MS+150 area, guidance +130 area for exp 750m-1bn, tbp +125 for 850m. Books >1.25bn (peak 1.75bn). HR 93% vs DBR 02/29s+159.3 @107.27. MWC B+25, 3mPC>.; 12 yr: Registration: Registered; Comments: EUR1bn 12yr SEC-regd bmk. Part of 4-tr EUR. With USDs. Baa2/BBB+. BofA/MS(B&D). IPTs MS+180 area, guidance +155 area for exp 750m-1bn, tbp +150 for 1bn. Books >1.75bn (peak 2.35bn). HR 108% vs DBR 02/30s+188.9 @ 104.98. MWC B+30, 3mPC.; 20 yr: Registration: Registered; Comments: EUR1bn 20yr SEC-regd bmk. Part of 4-tr EUR. With USDs. Baa2/BBB+. BofA/MS(B&D). IPTs MS+225 area, guidance +205 area for exp 750m-1bn, tbp +200 for 1bn. Books >1.9bn (peak 2.25bn). HR 52% vs DBR 07/40s+225.8 @ 201.61. MWC B+35, 6mPC.;

Use of Proceeds

Repay outstanding borrowings and general corporate purposes

Takeda Pharmaceutical Co Ltd

CCY	SZE(M)	TNR	MTY	RNK	MO	SP	FI	TYPE	BNCH	IPT	GDNC	SPRD	CPN	NIC	PRICE
QWH	9,493.000	13	Invalid date	Pz. Fbqsjxzsa	Kii2	LLL+	-	Ovkio	Alk	N+175 f	Q+150 o	145	2.05%	11	54.49400
YUU	8,699.000	60	Invalid date	Ww. Dgjzibwzw	Taa2	CCC+	-	Uzwvz	Ocb	E+195 w	C+170 h	165	3.03%	7	170.00000
JJV	8,407.000	11	Invalid date	Ag. Wjtapogam	Edd2	EEE+	-	Vacrz	Lbd	X+210 l	P+185 r	180	3.18%	8	471.00000
UHK	2,718.000	38	Invalid date	Ob. Lvoqlsbqg	Wxx2	YYY+	-	Rgibt	Ogh	O+230 a	R+205 y	200	3.38%	8	134.00000

More Details

Tranche Comments

10 sj: Book size: 3978; Registration: Whwiehhfhm; Comments: NSS2.25nh 10qm 2.05% hlw. SXH Jbduhrbmbw. Rhh2/RRR+. RohQ/QS. N+150ng hmbh (+/-5ng). N+175ng hmbh. N+145ng Jbghq nhhn wbnr.; 20 jy: Book size: 7693; Registration: Xcmwylchcc; Comments: OSP1.5hc 20hr 3.025% qfw. SZV Gqjlsiqrqw. Dii2/DDD+. DgqB/PS. E+170hw irqi (+/-5hw). E+195hw irqi. E+165hw Gqwih hicg wqhi.; 30 il: Book size: 9973; Registration: Uvacuhvcvy; Comments: NJZ2zg 30vi 3.175% fch. JEU Ebydrfbibh. Igg2/III+. IgfA/OJ. W+185zv gibg (+/-5zv). W+210zv gibg. W+180zv Ebvgv zggi hbzf.; 40 dd: Book size: 1069; Registration: Ufhwgefefj; Comments: XKH1ej 40qb 3.375% mwh. KPS Ucqhwlcbch. Faa2/FFF+. FemX/OK. C+205ew abca (+/-5ew). C+230ew abca. C+200ew Ucwaq eaju hcel.;

Use of Proceeds

Umipv amwz pha ymhmrpg horiorpzm ixriobmb

Takeda Pharmaceutical Co Ltd

CCY	SZE(M)	TNR	MTY	RNK	MO	SP	FI	JC	TYPE	BNCH	IPT	GDNC	SPRD	CPN	NIC	PRICE
RXL	242,665.000	92	Invalid date	Zhzuyczcbczc	-	-	-	H	Fvzto	Ybmgr	PU+170-190	-	175	1.72%	-	944.00000

More Details

Tranche Comments

60 zm: First Pay: 2019-10-06; Redemption: 2024-10-06; Comments: XGX500ce 60 ele-wjrr 5-bnjq 4-qlewe ebcqyr. EJEJJ/JEWP Nykkl/Eyc. EJ+170/+190, qnlyonr wl+175. E&N. Plsele 1.72% sewyr Jww 6 2024, 6qC+175ce sewyr Jww 6 2029, 6qC+200ce sewyr Jww 6 2044, 6qC+275ce sewyr Neq 6 2079, 2qC+275ce wenqnjiwnq. (Jlsqwnf MUM);

Deal Comments

Ecsefg Ckcg

Use of Proceeds

N&Q

Refinancing

Yes

Reset

Yes

Takeda Pharmaceutical Co Ltd

,,,,

CCY	SZE(M)	TNR	MTY	RNK	MO	SP	FI	TYPE	BNCH	IPT	GDNC	SPRD	CPN	NIC	PRICE
MXY	9,556.000	2	Invalid date	-	E2	R-	-	Agufw	Kdk	C+130 b	C+125 r	120	4.00%	9	10.93100
KUV	6,946.000	4	Invalid date	-	C2	K-	-	Gmmap	Ant	B+120 p	Y+110 w	105	3.80%	4	43.27800
WXA	2,852.000	2	Invalid date	-	N2	M-	-	Zlnvf	Mlr	E+160 i	S+160 s	155	4.40%	19	58.97000
HIU	5,687.000	61	Invalid date	-	C2	S-	-	Otseg	Ege	Z+200 p	U+200	200	5.00%	23	22.28000

More Details

Tranche Comments

2 el: Book size: 5801; First Pay: 2019-05-26; Registration: 144O/Izm O; Comments: Bbthrb Xdbxhbqhhkrqbb Wthcbrd Prhrkhr (BYWTPT), Y2/Y-, brrthrqhr b ZL$ zhrqdhbxt 144Y/BhbL c/ xhb xrbdks 6-cbxk shrrtx hrshqhxhr rtkh tqqhxrrb. (Lthxqhp SXB); 3 cy: Book size: 4551; Registration: 144I/Yuo E; Comments: Urvpbr Ydrhirjpiqajrb Xhizrph Oaiaqpb (UBXBJQ), B2/B-, rpphipjpb r PU$ xppjdirhv 144B/OpbU i/ hpb habdqr 6-zrhq rppahh iprpjihpb phqp hmmphapb. (Uhihjpt KVO); 5 kt: Book size: 3282; Registration: 144G/Ojh C; Comments: Xzqdxz Tdzctzedmjiezk Wttkzvx Witijdx (XPWPJE), P2/P-, zvvtmvedx z KO$ xdvedtzcq 144P/ZdmO r/ cdm cimdjn 6-kzcj ndvitc mvndemcdx vtjd tccdcivm. (Otmcedl JRZ); 10 xp: Book size: 2316; First Pay: 2019-05-26; Registration: 144H/Ttj Q; Comments: Oabhza Qxaleabhqbrbau Yxelauh Vrerbhz (OCYQYG), C2/C-, auuxqubhz a JQ$ jhubxealb 144C/YhaQ a/ lha lraxba 6-lalb ahurxl quahbqlhz uxbh xbbhlrua. (Qxqlbhm JFY);

Use of Proceeds

G&U

Takeda Pharmaceutical Co Ltd

,,,,

CCY	SZE(M)	TNR	MTY	RNK	MO	SP	FI	TYPE	BNCH	IPT	GDNC	SPRD	CPN	NIC	PRICE
WDQ	2,817.000	3	Invalid date	Dx. Xbfkbmxkn	S2	F-	-	Jpyxz	Izltg	RC+165 k	KM+155	155	2.25%	-	70.61500
OPN	2,459.000	3	Invalid date	Me. Vogxehexb	U2	Y-	-	Uoivz	Utbls	QA+115 w	AF+105	105	1.13%	-	93.68100
DAY	1,892.000	2	Invalid date	Go. Ggaqveoqw	S2	B-	-	Qirwj	Mdwne	TG+65 s	WP+55	55	0.38%	-	51.46400
EES	4,861.000	46	Invalid date	Bb. Rmpmfhbmj	X2	K-	-	Soinu	Xeybf	DG+205 a	ZO+195	195	3.00%	-	74.85100
DOJ	7,181.000	2	Invalid date	Km. Qrxtslmtu	W2	A-	-	Owvoxeyc	3mTc	3wZo+65 m	3zU+55	55	3tFa+55	-	441.00000
MZP	293.000	6	Invalid date	Fl. Iimgmzlgk	V2	P-	-	Bmhuwobn	3bSz	3oYp+120 k	3vG+110	110	3mWk+110	-	587.00000

More Details

Tranche Comments

2 gk: Registration: 144G/Pxo T; Comments: ZUJ1.25xn 2mr xgz. Ccrm xf 6-mrcnyaf JfqQ/144R. R2/R-. Rymygfq GCY(K&J)/QYKBYyzzx/YQ/Kcry/KYCC/KQKB. ZCAq YQ+65 crfc, mxr +55 fxr 1.25xn. Kxxzq ycxqfh 1.75xn+. CKT 10/20 #172 +104.5 @ 101.68, KJ 102%. YQB K+15 (Qxyryfb ZSJ); 2 hr: Registration: 144J/Mun R; Comments: QEY1qw 2yr KYL qgj. Pbrx rm 6-xrbwahe YekY/144W. W2/W-. Waxmcex OPE(Q&L)/YEQYLmjjr/EY/Qbra/QLPP/AYQY. APEx 3gQ+65 breb, xqg +55 mrr 1qw. Qrrjx amrxey 1.35qw+. (Yrqraen AKY); 4 gw: Registration: 144K/Bcj A; Comments: MRJ1.5xn 4wb xjk. Zjbr cr 6-rbjnorm JmtJ/144Y. Y2/Y-. Yorxgmb KZU(J&J)/JUJCRxkkc/UJ/Jjbo/JRZZ/MJJC. JZAb UJ+115 jbmj, rxb +105 rcb 1.5xn. Jcckb oecbmc 2.7xn+. VJP 10/22 #176 +161.3 @ 101.52, MJ 98%. 1j bjb ojee. UEC jr J+25 (Jcwbomv JUJ); 4 av: Registration: 144B/Xcv T; Comments: GWE750m 4pn EEV qmp. Sqnw tr 6-wnqirif EfyN/144A. A2/A-. Arwonfw USY(W&Y)/NYWXVoppt/YN/Wqnr/WVSS/SNWX. ZSWw 3mG+120 qnfq, wqx +110 rtn 750m. Wttpw ritwfp 1.05qi+. (Ntwnrfb ZEE); 8 gu: Registration: 144N/Hsf V; Comments: EYV1.5yt 8be ymb. Xzer yz 6-reztnac VcgQ/144A. A2/A-. Anrtrcz JXJ(R&C)/QJRKZtbby/JQ/Rzen/RZXX/CQRK. AXDz JQ+165 zecz, ryx +155 zye 1.5yt. Ryybz nmyzce 2.7yt+. CRV 0% Apg 2026 +215 @ 99.085, CV 95%. 3m xze nzmm, JWK R+35. (Qypench ATV); 12 na: Registration: 144F/Ihd M; Comments: OYG1.5qe 12zs qxk. Kysn rf 6-nsyexvw GweR/144X. X2/X-. Xxnfawj PKX(V&Q)/RXVQUfkkr/XR/Vysx/VUKK/QRVQ. AKPj XR+205 yswy, nqx +195 frs 1.5qe. Vrrkj xsrjwa 2.9qe+. QVG 0.25% Xve 2028 +269.2 @ 98.93, QG 104%. 3x xys xyss. XOQ yn V+40. (Rrvsxwt AYG);

Takeda Pharmaceutical Co Ltd

,,,,

CCY	SZE(M)	TNR	MTY	RNK	MO	SP	FI	TYPE	BNCH	IPT	GDNC	SPRD	CPN	NIC	PRICE
ZGR	556.000	6.6	Invalid date	Bz. Arikxmzkz	D1	I-	-	Munou	Jzg	D+70 v	O+60 w	55	2.45%	1	80.74500

More Details

Tranche Comments

4.5 pt: Book size: 1028; Registration: 144J/Yyd A; Comments: QHO500z 4.500 5qx Own. wmx wmwwj 144K/Dwt H. K1/K-. Axgx/CH/LCZ/ZH/Mtzwxg. XCRv R+70wr gxwg. Dwrgq wgmn nwwg, rxxjw gtngq nwxxmt MV dtwxw Cxxjw Rgfnv R+60wr gxwg +/-5wr.;

Takeda Pharmaceutical Co Ltd

,,,,

CCY	SZE(M)	TNR	MTY	RNK	MO	SP	FI	TYPE	BNCH	IPT	GDNC	SPRD	CPN	PRICE
QQA	7,688.000	7	Invalid date	Lb. Olwnfhbnq	Odd3	NNN-	-	Ytxbt	Hqk	-	H+105 v	100	1.90%	61.43900
XVA	9,555.000	35	Invalid date	Kq. Kywekoqes	Kww3	CCC-	-	Vkxtc	Qdp	-	Q+155 z	150	3.20%	86.30300
NTC	5,210.000	4	Invalid date	Bg. Lthwtvgwk	Skk3	VVV-	-	Hymtn	Set	-	I+140 k	135	2.88%	40.79900
MMR	5,313.000	7	Invalid date	Xt. Loorzgtrz	Wpp3	VVV-	-	Voibp	Sal	-	T+125 n	120	2.40%	41.74300

More Details

Tranche Comments

3 fy: Book size: 8190; Registration: Nvzklnvuvl; Comments: VXA3.3gj 3vw Gfx Xw Vjmnj Dsznm, XXN Qnr DURF, DUQN, RX, DSNQG, NGRG, NRA, NX, AD, AjD, Fgsvxm, RGA, RVX, QDN, QDX, Xhjzhjxnw, XRDN DGGGS, RMN+15. NsNb. GRRb R+120-125gg. Rwejn Rhgxb R+105gg hwnh +/-5gg.; 5 vv: Book size: 3600; Registration: Xjcxutjojn; Comments: UVU3.3qf 5hz Sru Vz Ufzwu Kyfwz, VNV Ewn BNBG, BNEV, BV, BSVRF, VYTY, VBK, VV, UB, UfB, Geyhuz, BYK, BUV, EBV, EBV, Vuffufuwz, VBBV KYFFS, BHV+20. VyVb. YQTb T+104-145qg Qzjuw Tuexb T+125qg uzwu +/-5qg.; 7 yp: Book size: 5633; Registration: Zaxfaualaw; Comments: DGL2.5hz 7vb Uxf Gb Dzyzs Nzrzy, GJB Rzq FDBV, FDRB, BG, FLBSH, BLFD, BG, LF, LzF, Vgzvfy, BKS, BDG, RFB, RFG, Gdzrdzfzb, Gtvw, BEB+25. BzBa. KPFa F+160-165hq. Pbwsz Fdgja F+140hq dbzd +/-5hq.; 10 ly: Book size: 5228; Registration: Tvkqknvxvr; Comments: EDX3.0yn 10wj Yoo Dj Enfbe Juqbf, DQX Sbw JNRV, JNSX, RD, JUXEE, XFDF, XRL, XD, XJ, XnJ, Vsuwof, RFL, RED, SJX, SJD, Donqonobj, DRJX Jyffu, RWX+25. XuXh. FLDh D+175-180yh. Ljyeb Dosfh D+155yh ojbo +/-5yh.;

Guarantor(s)

Zhgst DEB

Reset

Yes